In vitro and in vivo evaluation of 64Cu-radiolabeled kccysl peptides for targeting epidermal growth factor receptor-2 in breast carcinomas

Authors

Senthil R. Kumar, University of Missouri Columbia
Fabio A. Gallazzi, University of Missouri Columbia
Riccardo Ferdani, Washington University School of Medicine in St. Louis
Carolyn J. Anderson, Washington University School of Medicine in St. LouisFollow
Thomas P. Quinn, University of Missouri Columbia
Susan L. Deutscher, University of Missouri Columbia

Journal

Cancer Biotherapy & Radiopharmaceuticals

Publication Date

1-5-2011

Volume

25

Issue

6

Inclusive Pages

693-703

Document Type

Open Access Publication

DOI

10.1089/cbr.2010.0820

Rights and Permissions

Senthil R. Kumar, Fabio A. Gallazzi, Riccardo Ferdani, Carolyn J. Anderson, Thomas P. Quinn, and Susan L. Deutscher. Cancer Biotherapy & Radiopharmaceuticals. December 2010, 25(6): 693-703. doi:10.1089/cbr.2010.0820.

Recommended Citation

Kumar, Senthil R.; Gallazzi, Fabio A.; Ferdani, Riccardo; Anderson, Carolyn J.; Quinn, Thomas P.; and Deutscher, Susan L., "In vitro and in vivo evaluation of 64Cu-radiolabeled kccysl peptides for targeting epidermal growth factor receptor-2 in breast carcinomas." Cancer Biotherapy & Radiopharmaceuticals. 25, 6. 693-703. (2011).
https://digitalcommons.wustl.edu/open_access_pubs/2804